RSRachel Slangen

Rachel Slangen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rachel Slangen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Alfons G. Kessels

    Department of Clinical Epidemiology and Medical Technology, Maastricht University Medical Centre+, Maastricht, The Netherlands

    2 shared publications
  • Carmen D. Dirksen

    Department of Clinical Epidemiology and Medical Technology, Maastricht University Medical Centre+, Maastricht, The Netherlands; CAPHRI School of Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands

    2 shared publications
  • Catharina G. Faber

    Department of Neurology, Maastricht University Medical Centre+, Maastricht, The Netherlands

    2 shared publications
  • Elbert A. Joosten

    Department of Anesthesiology and Pain Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands

    2 shared publications
  • Nicolaas Schaper

    CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, the Netherlands

    2 shared publications
  • Robert T. van Dongen

    Department of Anesthesiology, Pain, and Palliative Care, Radboud University Medical Centre, Nijmegen, the Netherlands

    2 shared publications

Latest Publications

  • A Trial-Based Economic Evaluation Comparing Spinal Cord Stimulation With Best Medical Treatment in Painful Diabetic Peripheral Neuropathy

    by Rachel Slangen, Catharina G. Faber, Nicolaas C. Schaper, Elbert A. Joosten, Robert T. van Dongen, Alfons G. Kessels, Maarten van Kleef, Carmen D. Dirksen


  • Top Cited Papers

    Spinal Cord Stimulation and Pain Relief in Painful Diabetic Peripheral Neuropathy: A Prospective Two-Center Randomized Controlled Trial

    by Rachel Slangen, Nicolaas C. Schaper, Catharina G. Faber, Elbert A. Joosten, Carmen D. Dirksen, Robert T. van Dongen, Alfons G. Kessels, Maarten van Kleef

    OBJECTIVE Painful diabetic peripheral neuropathy (PDPN) is a common complication of diabetes mellitus. Unfortunately, pharmacological treatment is often partially effective or accompanied by unacceptable side effects, and new treatments are urgently needed. Small observational studies suggested that spinal cord stimulation (SCS) may have positive effects. RESEARCH DESIGN AND METHODS We performed a multicenter randomized clinical trial in 36 PDPN patients with severe lower limb pain not responding to conventional therapy. Twenty-two patients were randomly assigned to SCS in combination with the best medical treatment (BMT) (SCS group) and 14 to BMT only (BMT group). The SCS system was implanted only if trial stimulation was successful. Treatment success was defined as ≥50% pain relief during daytime or nighttime or “(very) much improved” for pain and sleep on the patient global impression of change (PGIC) scale at 6 months. RESULTS Trial stimulation was successful in 77% of the SCS patients. Treatment success was observed in 59% of the SCS and in 7% of the BMT patients (P < 0.01). Pain relief during daytime and during nighttime was reported by 41 and 36% in the SCS group and 0 and 7% in the BMT group, respectively (P < 0.05). Pain and sleep were “(very) much improved” in 55 and 36% in the SCS group, whereas no changes were seen in the BMT group, respectively (P < 0.001 and P < 0.05). One SCS patient died because of a subdural hematoma. CONCLUSIONS Treatment success was shown in 59% of patients with PDPN who were treated with SCS over a 6-month period, although this treatment is not without risks.